| Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma N Braekeveldt, K Von Stedingk, S Fransson, A Martinez-Monleon, ... Cancer research 78 (20), 5958-5969, 2018 | 50 | 2018 |
| 11q deletion or ALK activity curbs DLG2 expression to maintain an undifferentiated state in neuroblastoma JT Siaw, N Javanmardi, J Van den Eynden, DE Lind, S Fransson, ... Cell reports 32 (12), 108171, 2020 | 34 | 2020 |
| Differential effects of MAPK pathway inhibitors on migration and invasiveness of BRAFV600E mutant thyroid cancer cells in 2D and 3D culture C Ingeson-Carlsson, A Martinez-Monleon, M Nilsson Experimental cell research 338 (2), 127-135, 2015 | 28 | 2015 |
| Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance S Fransson, A Martinez-Monleon, M Johansson, RM Sjöberg, C Björklund, ... Scientific Reports 10 (1), 1-14, 2020 | 27 | 2020 |
| Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup A Martinez-Monleon, H Kryh Öberg, J Gaarder, AP Berbegall, ... Scientific Reports 12 (1), 1-17, 2022 | 9 | 2022 |
| Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma A Martinez‑Monleon, J Gaarder, A Djos, P Kogner, S Fransson International Journal of Oncology 62 (2), 1-11, 2023 | 4 | 2023 |
| TC-hunter: identification of the insertion site of a transgenic gene within the host genome V Börjesson, A Martinez-Monleon, S Fransson, P Kogner, JI Johnsen, ... BMC genomics 23 (1), 1-11, 2022 | 1 | 2022 |
| Molecular and genetic studies in high-risk neuroblastoma A Martinez-Monleon | 1 | 2021 |
| Identification of mutational signatures in high-risk neuroblastoma patients SE Reinsbach, M Larsson, A Martinez-Monleon, RM Sjöberg, ... Cancer Research 78 (13 Supplement), 2246-2246, 2018 | 1 | 2018 |
| Genomic changes in relapsed neuroblastoma S Fransson, AM Monleon, A Djos, S Reinsbach, RM Sjoberg, P Sikora, ... Cancer Research 79 (13 Supplement), 1692-1692, 2019 | | 2019 |
| Whole genome sequencing for precision medicine in high-risk neuroblastoma patients: Translation from research to clinical practice in Sweden SM Fransson, A Martinez-Monleon, S Reinsbach, P Sikora, RM Sjoberg, ... Cancer Research 78 (13 Supplement), 3185-3185, 2018 | | 2018 |
| Exome-and whole genome sequencing for clinical evaluation and precision medicine in neuroblastoma AM Monleon, S Reinsbach, N Javanmardi, A Djos, RM Sjoberg, P Kogner, ... Cancer Research 77 (13 Supplement), 4867-4867, 2017 | | 2017 |
